PRAME and neoplasm: EIF1AX mutations were associated with Class 1 tumors (p < 0.0001), PRAME(-) status (p < 0.0001), decreased tumor diameter (p < 0.0001), lack of ciliary body involvement (p < 0.0001), and male sex (p < 0.0001).